The finding of MYC amplification in this case of AVG-associated angiosarcoma expands the spectrum of recognized clinicopathologic subtypes of angiosarcoma bearing this aberration and suggests they share similar pathogenesis. This evidence concerns the gene MYC and angiosarcoma.